Liquid AI's LFM2 Beats GPT-5 and Claude on Aging Research Tasks

Liquid AI and Insilico Medicine released two small LFM2 variants that beat GPT-5, Gemini-3.1-Pro, and Claude Opus on aging biology benchmarks.

Source

Liquid AI

Published

Sep 17, 2026, 3:29 PM

Author

AlphaSignal Newsroom

Read

1 min read

Liquid AI and Insilico Medicine released two small LFM2 variants that beat GPT-5, Gemini-3.1-Pro, and Claude Opus on aging biology benchmarks.

Reporting is indexed from AlphaSignal. Rights remain with the original publisher and cited sources.

Next reads